v3.25.0.1
Insider Trading Arrangements
3 Months Ended 12 Months Ended
Jan. 26, 2025
shares
Jan. 26, 2025
shares
Trading Arrangements, by Individual    
Material Terms of Trading Arrangement  
The following members of our Board of Directors and/or officers adopted, modified or terminated a trading arrangement that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c), or a Rule 10b5-1 Trading Arrangement:
NameTitle of Director or OfficerActionDateTotal Shares of Common Stock to be SoldExpiration Date
Aarti ShahDirectorTerminationNovember 25, 2024
29,000*
N/A
Aarti ShahDirectorAdoptionNovember 25, 202439,000March 31, 2026
John O. DabiriDirectorAdoptionDecember 9, 2024
3,396**
December 2, 2025
*The Rule 10b5-1 Trading Arrangement was adopted on September 27, 2024 for sales through March 31, 2026. No shares were sold under the plan prior to termination.
**Estimated assuming our closing stock price as of January 24, 2025. The number of shares is based on an estimate because the plan specifies a formulaic dollar amount of shares to be sold.
Non-Rule 10b5-1 Arrangement Adopted false  
Non-Rule 10b5-1 Arrangement Terminated false  
John O. Dabiri [Member]    
Trading Arrangements, by Individual    
Name John O. Dabiri  
Title members of our Board of Directors  
Rule 10b5-1 Arrangement Adopted true  
Adoption Date December 9, 2024  
Expiration Date December 2, 2025  
Arrangement Duration 358 days  
Aggregate Available 3,396 3,396
Aarti Shah November 25, 2024 10b5-1 Trading arrangement [Member] | Ms Aarti Shah [Member]    
Trading Arrangements, by Individual    
Name Aarti Shah  
Title members of our Board of Directors  
Rule 10b5-1 Arrangement Adopted true  
Adoption Date November 25, 2024  
Expiration Date March 31, 2026  
Arrangement Duration 491 days  
Aggregate Available 39,000 39,000
Aarti Shah September 27, 2024 10b5-1 Trading arrangement [Member] | Ms Aarti Shah [Member]    
Trading Arrangements, by Individual    
Name Aarti Shah  
Title members of our Board of Directors  
Rule 10b5-1 Arrangement Terminated true  
Termination Date November 25, 2024  
Aggregate Available 29,000 29,000